Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas

By Shi Zonggao   Liu Yueying   Johnson Jeffrey   Stack M.  

Molecular and Cellular Biochemistry, Vol. 357, Iss. 1-2, 2011-11 ,pp. : 151-161

Springer Publishing Company

Access to resources Recommend Favorite

Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus

By Toldi Gergely   Szalay Balázs   Bekő Gabriella   Bocskai Márta   Deák Magdolna   Kovács László   Vásárhelyi Barna   Balog Attila  

Biomarkers, Vol. 17, Iss. 8, 2012-12 ,pp. : 758-763

Informa Healthcare

Access to resources Recommend Favorite

Pregnancy Zone Protein–Tissue-Type Plasminogen Activator Complexes Bind to Low-Density Lipoprotein Receptor-Related Protein (LRP)

By Sánchez M.C.   Chiabrando G.A.   Vides M.A.  

Archives of Biochemistry and Biophysics, Vol. 389, Iss. 2, 2001-05 ,pp. : 218-222

Elsevier

Access to resources Recommend Favorite

Crystals of the Urokinase Type Plasminogen Activator Variant &bgr;c-uPA in Complex with Small Molecule Inhibitors Open the Way towards Structure-based Drug Design

By Zeslawska E.   Schweinitz A.   Karcher A.   Sondermann P.   Sperl S.   Stürzebecher J.   Jacob U.  

Journal of Molecular Biology, Vol. 301, Iss. 2, 2000-08 ,pp. : 465-475

Academic Press

Access to resources Recommend Favorite

QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors

By Karthikeyan C.   Moorthy N.S. Hari Narayana   Trivedi Piyush  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. : 6-13

Informa Healthcare

Access to resources Recommend Favorite